home / stock / hrtx / hrtx quote
Last: | $2.71 |
---|---|
Change Percent: | 0.72% |
Open: | $2.75 |
Close: | $2.71 |
High: | $2.9599 |
Low: | $2.695 |
Volume: | 1,817,200 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.71 | $2.75 | $2.71 | $2.9599 | $2.695 | 1,817,200 | 04-18-2024 |
$2.77 | $2.95 | $2.77 | $3.02 | $2.77 | 1,557,084 | 04-17-2024 |
$2.93 | $2.86 | $2.93 | $2.9806 | $2.86 | 1,650,747 | 04-16-2024 |
$2.95 | $2.89 | $2.95 | $3.075 | $2.86 | 2,823,658 | 04-15-2024 |
$2.91 | $2.93 | $2.91 | $3.07 | $2.86 | 2,131,427 | 04-12-2024 |
$2.94 | $2.71 | $2.94 | $2.94 | $2.68 | 1,367,685 | 04-11-2024 |
$2.73 | $2.74 | $2.73 | $2.83 | $2.665 | 1,589,902 | 04-10-2024 |
$2.8 | $2.76 | $2.8 | $2.8309 | $2.71 | 623,051 | 04-09-2024 |
$2.75 | $2.75 | $2.75 | $2.81 | $2.7 | 1,028,834 | 04-08-2024 |
$2.75 | $2.56 | $2.75 | $2.751 | $2.5 | 995,410 | 04-05-2024 |
$2.57 | $2.62 | $2.57 | $2.65 | $2.53 | 1,190,883 | 04-04-2024 |
$2.57 | $2.55 | $2.57 | $2.63 | $2.53 | 952,370 | 04-03-2024 |
$2.55 | $2.65 | $2.55 | $2.67 | $2.52 | 1,292,775 | 04-02-2024 |
$2.71 | $2.8 | $2.71 | $2.82 | $2.64 | 1,265,818 | 04-01-2024 |
$2.77 | $2.74 | $2.77 | $2.81 | $2.67 | 1,106,763 | 03-29-2024 |
$2.77 | $2.74 | $2.77 | $2.81 | $2.67 | 1,106,763 | 03-28-2024 |
$2.74 | $2.83 | $2.74 | $2.83 | $2.67 | 1,225,830 | 03-27-2024 |
$2.74 | $2.98 | $2.74 | $3.08 | $2.73 | 1,978,408 | 03-26-2024 |
$2.95 | $2.97 | $2.95 | $3.08 | $2.94 | 1,310,142 | 03-25-2024 |
$2.97 | $3.04 | $2.97 | $3.08 | $2.95 | 1,263,904 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City PR Newswire SAN DIEGO , April 11, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it will host an Investor Day on...
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference PR Newswire SAN DIEGO , March 28, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that Craig C...
Tuesday, Heron Therapeutics Inc (NASDAQ:HRTX) reported a fourth-quarter 2023 EPS of $(0.07), beating the consensus of $(0.16). Sales incr...